Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$29.49
0.431.48%
al cierre: Nov 21, 4:00 PM EST
$29.50
0.010.03%
After hour: 4:08 PM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Cinemark Holdings Inc tiene un precio objetivo de consenso de $30.71 basado en las calificaciones de 17 analistas. El máximo es $37, emitido por JP Morgan el noviembre 6, 2025. El mínimo es $14, emitido por Credit Suisse el mayo 8, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por JP Morgan, Morgan Stanley y JP Morgan el noviembre 6, 2025, octubre 21, 2025 y octubre 9, 2025, respectivamente. Con un precio objetivo promedio de $36.33 entre JP Morgan, Morgan Stanley y JP Morgan, hay una 23.16% upside implícita para Cinemark Holdings Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
JP Morgan
Morgan Stanley
Barrington Research
Roth Capital
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Cinemark Holdings
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/06/2025 | 25.42% | JP Morgan | $38 → $37 | Maintains | Overweight | |||
10/21/2025 | 15.25% | Morgan Stanley | $35 → $34 | Maintains | Overweight | |||
10/09/2025 | 28.81% | JP Morgan | $37 → $38 | Maintains | Overweight | |||
09/23/2025 | 22.03% | Barrington Research | $36 → $36 | Maintains | Outperform | |||
08/04/2025 | 15.25% | Roth Capital | $36 → $34 | Maintains | Buy | |||
08/04/2025 | 22.03% | Barrington Research | $36 → $36 | Reiterates | Outperform → Outperform | |||
08/04/2025 | 11.86% | Wells Fargo | $36 → $33 | Maintains | Overweight | |||
07/11/2025 | 25.42% | Wedbush | $32 → $37 | Upgrade | Neutral → Outperform | |||
07/10/2025 | 22.03% | Deutsche Bank | → $36 | Initiates | → Buy | |||
07/09/2025 | 18.64% | Roth Capital | $36 → $35 | Maintains | Buy | |||
07/02/2025 | 18.64% | Benchmark | $35 → $35 | Reiterates | Buy → Buy | |||
05/05/2025 | 22.03% | Barrington Research | $36 → $36 | Maintains | Outperform | |||
05/05/2025 | 18.64% | JP Morgan | $34 → $35 | Maintains | Overweight | |||
04/28/2025 | 8.47% | Wedbush | $32 → $32 | Reiterates | Neutral → Neutral | |||
04/11/2025 | 15.25% | JP Morgan | $30 → $34 | Upgrade | Neutral → Overweight | |||
02/20/2025 | 18.64% | Macquarie | $35 → $35 | Maintains | Outperform | |||
02/20/2025 | 18.64% | Morgan Stanley | $40 → $35 | Maintains | Overweight | |||
02/20/2025 | 1.69% | JP Morgan | $31 → $30 | Maintains | Neutral | |||
02/20/2025 | 18.64% | Benchmark | $40 → $35 | Maintains | Buy | |||
02/20/2025 | 22.03% | Barrington Research | $40 → $36 | Maintains | Outperform | |||
02/19/2025 | 35.59% | Barrington Research | $40 → $40 | Maintains | Outperform | |||
01/30/2025 | 5.08% | JP Morgan | $29 → $31 | Maintains | Neutral | |||
01/29/2025 | 22.03% | Wells Fargo | $38 → $36 | Maintains | Overweight | |||
01/10/2025 | 35.59% | Benchmark | $40 → $40 | Reiterates | Buy → Buy | |||
12/18/2024 | 35.59% | Morgan Stanley | $35 → $40 | Maintains | Overweight | |||
12/03/2024 | 35.59% | Benchmark | $32 → $40 | Maintains | Buy | |||
11/27/2024 | 28.81% | Wells Fargo | $35 → $38 | Maintains | Overweight | |||
11/04/2024 | 22.03% | Barrington Research | $36 → $36 | Maintains | Outperform | |||
11/01/2024 | 18.64% | Wells Fargo | $31 → $35 | Maintains | Overweight | |||
11/01/2024 | 8.47% | Wedbush | $32 → $32 | Downgrade | Outperform → Neutral | |||
11/01/2024 | 15.25% | Macquarie | $32 → $34 | Maintains | Outperform | |||
10/31/2024 | 22.03% | Barrington Research | → $36 | Upgrade | Market Perform → Outperform | |||
10/29/2024 | 8.47% | Wedbush | $31 → $32 | Maintains | Outperform | |||
10/14/2024 | -1.69% | JP Morgan | $25 → $29 | Maintains | Neutral | |||
10/11/2024 | 18.64% | Morgan Stanley | $29 → $35 | Maintains | Overweight | |||
10/10/2024 | 5.08% | Wells Fargo | $28 → $31 | Maintains | Overweight | |||
10/10/2024 | 11.86% | Roth MKM | $30 → $33 | Maintains | Buy | |||
09/19/2024 | -32.2% | Goldman Sachs | $16 → $20 | Maintains | Sell | |||
09/03/2024 | 5.08% | Wedbush | $28 → $31 | Maintains | Outperform | |||
08/28/2024 | — | Barrington Research | — | Downgrade | Outperform → Market Perform | |||
08/27/2024 | 5.08% | B. Riley Securities | $31 → $31 | Downgrade | Buy → Neutral | |||
08/05/2024 | -1.69% | Morgan Stanley | $26 → $29 | Maintains | Overweight | |||
08/05/2024 | 1.69% | Roth MKM | $28 → $30 | Maintains | Buy | |||
08/05/2024 | -5.08% | Barrington Research | $24 → $28 | Maintains | Outperform | |||
08/05/2024 | 5.08% | B. Riley Securities | $27 → $31 | Maintains | Buy | |||
08/05/2024 | -15.25% | JP Morgan | $22 → $25 | Maintains | Neutral | |||
08/02/2024 | -18.64% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
07/29/2024 | -15.25% | Wedbush | $25 → $25 | Reiterates | Outperform → Outperform | |||
07/18/2024 | -11.86% | Morgan Stanley | $24 → $26 | Maintains | Overweight | |||
07/09/2024 | -18.64% | Macquarie | $21 → $24 | Maintains | Outperform | |||
07/08/2024 | -8.47% | B. Riley Securities | $16 → $27 | Upgrade | Neutral → Buy | |||
07/01/2024 | -22.03% | Benchmark | $23 → $23 | Reiterates | Buy → Buy | |||
06/27/2024 | -15.25% | Wedbush | $25 → $25 | Reiterates | Outperform → Outperform | |||
06/24/2024 | -11.86% | Roth MKM | $19 → $26 | Upgrade | Neutral → Buy | |||
06/17/2024 | -18.64% | Barrington Research | $24 → $24 | Maintains | Outperform | |||
05/06/2024 | -18.64% | Barrington Research | $24 → $24 | Reinstates | Outperform → Outperform | |||
05/03/2024 | -22.03% | Benchmark | $23 → $23 | Reiterates | Buy → Buy | |||
05/03/2024 | -45.76% | B. Riley Securities | $14 → $16 | Maintains | Neutral | |||
04/25/2024 | -22.03% | Wedbush | $23 → $23 | Reiterates | Outperform → Outperform | |||
04/22/2024 | -18.64% | Barrington Research | $24 → $24 | Reiterates | Outperform → Outperform | |||
04/18/2024 | -22.03% | Wedbush | $20 → $23 | Maintains | Outperform | |||
04/10/2024 | -25.42% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
04/10/2024 | -35.59% | Roth MKM | $17 → $19 | Maintains | Neutral | |||
04/08/2024 | -35.59% | JP Morgan | $17 → $19 | Maintains | Neutral | |||
04/05/2024 | -22.03% | Wells Fargo | $13 → $23 | Upgrade | Underweight → Overweight | |||
04/03/2024 | -25.42% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | |||
02/13/2024 | -32.2% | Wedbush | $20 → $20 | Reiterates | Outperform → Outperform | |||
02/06/2024 | -45.76% | JP Morgan | $18 → $16 | Maintains | Neutral | |||
01/11/2024 | -59.32% | Goldman Sachs | $16 → $12 | Maintains | Sell | |||
01/02/2024 | -49.15% | B. Riley Securities | $23 → $15 | Downgrade | Buy → Neutral | |||
12/20/2023 | -55.93% | Wells Fargo | $16 → $13 | Downgrade | Equal-Weight → Underweight | |||
10/24/2023 | -45.76% | Wells Fargo | $18 → $16 | Maintains | Equal-Weight | |||
10/06/2023 | -25.42% | Benchmark | $21 → $22 | Maintains | Buy | |||
09/19/2023 | -28.81% | Benchmark | → $21 | Reiterates | Buy → Buy | |||
08/07/2023 | -25.42% | Barrington Research | $20 → $22 | Reiterates | Outperform → Outperform | |||
08/07/2023 | -18.64% | Morgan Stanley | $22 → $24 | Maintains | Overweight | |||
08/07/2023 | -32.2% | Wedbush | → $20 | Reiterates | Outperform → Outperform | |||
08/01/2023 | -32.2% | Wedbush | → $20 | Reiterates | Outperform → Outperform | |||
07/19/2023 | -38.98% | JP Morgan | $21 → $18 | Downgrade | Overweight → Neutral | |||
07/18/2023 | -25.42% | Morgan Stanley | $22 → $22 | Reiterates | Overweight → Overweight | |||
07/12/2023 | -42.37% | Roth MKM | $18 → $17 | Maintains | Neutral | |||
07/12/2023 | -22.03% | B. Riley Securities | $20 → $23 | Upgrade | Neutral → Buy | |||
07/10/2023 | -35.59% | Benchmark | → $19 | Reiterates | Buy → Buy | |||
06/14/2023 | -32.2% | B. Riley Securities | $21 → $20 | Downgrade | Buy → Neutral | |||
05/26/2023 | -35.59% | Benchmark | → $19 | Reiterates | Buy → Buy | |||
05/09/2023 | -32.2% | Barrington Research | $19 → $20 | Maintains | Outperform | |||
05/08/2023 | -28.81% | B. Riley Securities | $20 → $21 | Maintains | Buy | |||
05/08/2023 | -32.2% | Macquarie | $18 → $20 | Maintains | Outperform | |||
05/08/2023 | -25.42% | Morgan Stanley | $21 → $22 | Maintains | Overweight | |||
05/08/2023 | -32.2% | Wedbush | → $20 | Reiterates | → Outperform | |||
05/08/2023 | -52.54% | Credit Suisse | → $14 | Reiterates | → Neutral | |||
04/21/2023 | -57.63% | Goldman Sachs | $11 → $12.5 | Maintains | Sell | |||
04/17/2023 | -28.81% | Morgan Stanley | $16 → $21 | Maintains | Overweight | |||
04/10/2023 | -32.2% | B. Riley Securities | $15 → $20 | Maintains | Buy | |||
04/10/2023 | -42.37% | Benchmark | → $17 | Reiterates | → Buy | |||
04/06/2023 | -52.54% | Credit Suisse | $12 → $14 | Maintains | Neutral | |||
03/28/2023 | -42.37% | Benchmark | → $17 | Reiterates | → Buy | |||
02/27/2023 | -42.37% | JP Morgan | $15 → $17 | Maintains | Overweight | |||
02/27/2023 | -42.37% | Benchmark | → $17 | Reiterates | → Buy | |||
02/27/2023 | -49.15% | B. Riley Securities | $13 → $15 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Cinemark Holdings (CNK)?
El último precio objetivo de Cinemark Holdings (NYSE:CNK) fue comunicado por JP Morgan el noviembre 6, 2025. La firma de analistas fijó un precio objetivo para $37.00 que espera CNK a rise dentro de 12 meses (un posible 25.42% upside). 27 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Cinemark Holdings (CNK)?
La última calificación de analistas para Cinemark Holdings (NYSE:CNK) fue proporcionada por JP Morgan, y Cinemark Holdings mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Cinemark Holdings (CNK)?
La última revisión al alza de Cinemark Holdings Inc se produjo en julio 11, 2025, cuando Wedbush elevó su precio objetivo a $37. Wedbush anteriormente tenía a neutral para Cinemark Holdings Inc.
¿Cuándo fue la última revisión a la baja de Cinemark Holdings (CNK)?
La última revisión a la baja de Cinemark Holdings Inc se produjo en noviembre 1, 2024, cuando Wedbush cambió su precio objetivo de $32 a $32 para Cinemark Holdings Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Cinemark Holdings (CNK)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Cinemark Holdings, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Cinemark Holdings se registró el noviembre 6, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 6, 2026.
¿Es correcta la calificación de los analistas sobre Cinemark Holdings (CNK)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Cinemark Holdings (CNK) fue un mantuvo con un precio objetivo de $38.00 a $37.00. El precio actual al que cotiza Cinemark Holdings (CNK) es de $29.50, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.